Hexstone Capital LLC → Actuate Therapeutics, Inc. ACTU

Stake: — Shares: — Class: Common Stock, par value $0.000001 per share

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 16/100

Disqualifiers: ACTIVE_DILUTION_SHELF: Active 424B5 / S-3 shelf takedown within ±30d

Passive Schedule 13G filer baseline
Moderate short days-to-cover (4.7 DTC)
Short interest building (+40.4% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.71

1,867,593 shares short · +40.4% vs prior

Other 13D/G Filings on Actuate Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-06-30	SCHEDULE	BIOS Fund I, LP	49.80%	10,267,232	view →

Other Filings by Hexstone Capital LLC

Filed	Form	Issuer	Stake	Shares
2026-07-09	SCHEDULE 13G	Jet.AI Inc. JTAI	—	—	view →
2026-05-29	SCHEDULE 13G	Global Mofy AI Ltd GMM	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →